Delivery Order SPE2DB24D2217-SPE2DB25FJXRC
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on June 13, 2025, for the supply of Brimonidine-Timolol 0.2%-0.5% ophthalmic medication in a 10 mL formulation, with a ceiling value of $73,571.23. This competitively awarded, firm fixed-price delivery order is scheduled for completion by June 16, 2025, and will be fulfilled from the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order valued at $4,237.09 to AmerisourceBergen Drug Corp for Brimonidine Tartrate 0.15% ophthalmic drops (15mL) on August 26, 2025, with an ultimate completion date of August 27, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract with performance at the contractor's Conshohocken, Pennsylvania facility. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $3,193.50 firm fixed price delivery order to AmerisourceBergen Drug Corp for Brimonidine Tartrate 0.15% ophthalmic drops (10mL) on September 19, 2025, with an ultimate completion date of September 22, 2025. This non-set-aside competitive award was fulfilled by AmerisourceBergen's Corporate Office division, with performance to be completed at the vendor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,240.86 to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Brimonidine Tartrate 0.15% ophthalmic drops in 10ml units. This is a firm fixed price contract with no set-aside designation, performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of June 6, 2025. The award represents a competitive procurement under AmerisourceBergen Drug Corp's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,818.40 to AmerisourceBergen Drug Corp for the supply of Timolol 0.5% Gel-Solution 5mL, a topical ophthalmic medication commonly used to treat glaucoma and ocular hypertension. This firm fixed-price delivery order, issued on August 8, 2025, was competitively awarded with no set-aside designation and carries an ultimate completion date of August 11, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $2,773.45 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561935300 BRIMONIDINE-TIMOLOL 0.2%-0.5% 10ML. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The single day order is for the branded ophthalmic solution and runs from August 24 through August 25, 2023. As a top pharmaceutical supplier, Amerisourcebergen will deliver the requested medications to the DLA, the Department of...
- The Defense Logistics Agency awarded a $1,960.01 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Brimonidine Tartrate 0.1% ophthalmic drops (5mL) with an ultimate completion date of July 31, 2025. This delivery order, issued on July 30, 2025, is classified as a child contract and was awarded without a set-aside designation through competitive procurement. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Brimonidine...
- The Defense Logistics Agency awarded a delivery order valued at $2,109.14 to AmerisourceBergen Drug Corp for the supply of Timolol 0.25% Gel-Solution 5ML, an ophthalmic medication used to treat glaucoma and ocular hypertension. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 13, 2025. The contract was fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 10 milliliters of Brimonidine Tartrate 0.15% ophthalmic drops, valued at $1,213.60, with a completion date of August 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. As a delivery order, this award falls under a larger indefinite delivery contract (IDC) vehicle that...
- The Defense Logistics Agency awarded a $971.74 delivery order contract to Amerisourcebergen Drug Corporation for the supply of 10mL bottles of 0.2%-0.5% brimonidine-timolol ophthalmic solution. The contract has a firm fixed price and calls for delivery to a location in Conshohocken, Pennsylvania, with performance periods spanning August 17-18, 2023. No major subcontractors or set aside designations were indicated. The DLA functions to support military readiness by procuring and providing...
- SPE2DB24D2217Indefinite Delivery Contract
- SPE2DB24D2217-SPE2DB25FJXRCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,256.19 to AmerisourceBergen Drug Corp for the supply of Brimonidine-Timolol 0.2%-0.5% ophthalmic solution in a 10 milliliter formulation, with completion expected by August 29, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's comprehensive $999.999 billion prime indefinite delivery contract (SPE2DX) with DLA Troop Support Medical, which runs through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare systems. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains an extensive portfolio of federal medical procurement contracts with DLA covering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The company's contract awards demonstrate consistent capability to fulfill federal medical supply requirements through open competition, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 8/28/25 |